Osteoarthritis Clinical Trials 2024

Osteoarthritis Clinical Trials 2024

Osteoarthritis research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in OA clinical trials today.

Trials for Hip Osteoarthritis Patients

Trials for OA Patients

Phase 3 Trials

View More Related Trials

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to osteoarthritis

What are the top hospitals conducting osteoarthritis research?

Osteoarthritis, a condition characterized by joint pain and stiffness, affects millions of people worldwide. In the quest for innovative treatments and therapies, several top hospitals are leading the way in clinical trials. NYU Langone Health in New york boasts five active osteoarthritis trials, with an impressive history of seven conducted trials since their first recorded study in 2019. Similarly, Brigham and Women's Hospital in Boston has been actively involved in advancing knowledge about this debilitating condition with five ongoing trials and a total of 12 completed studies since their initial investigation back in 2008.

On the West Coast, the University of Washington is making significant strides as well. With four active osteoarthritis trials underway and a notable track record of 11 previous investigations dating back to 2009 when they first embarked on understanding this disease better.The Rush University Medical Center located at Chicago contributes actively too; currently conducting four osteoarthritis clinical tests while holding records from over three decades' worth - thirty-four considered experiments initiated around them since recording their earliest trial related to this field starting way back until2006.

Meanwhile,the Anderson Orthopaedic Research Institute situated Alexandria ensures its presence among these esteemed institutions by participating earnestly through maintaining three ongoing osteoarthritis experimental researches along with having made remarkable contributions across eleven prior cases which can be traced origins earlier as1998.Not only do these hospitals offer hope to individuals suffering from osteoarthritis but collectively they represent collective commitment towards finding more effective ways to manage this chronic condition that impacts daily lives significantly.

With each new trial conducted at these renowned medical centers comes valuable insights into potential breakthroughs for treating and alleviating symptoms associated with osteoarthritis. By working together tirelessly towards discovering cutting-edge interventions,researchers continue pushing boundaries and paving the path towards improved quality of life for those affected by this widespread ailment

Which are the best cities for osteoarthritis clinical trials?

When it comes to osteoarthritis clinical trials, several cities stand out for their ongoing research and opportunities for participation. In New york, there are 24 active trials exploring treatments such as TG-C, Vancomycin powder, and pain coping skills interventions. Chicago offers 19 active trials focused on innovative approaches like low-load treadmill walking exercise and RTX-GRT7039. Miami has 13 active trials investigating treatments such as Pentosan Polysulfate Sodium and intervention options with TG-C. Lastly, in Boston, researchers are conducting 12 studies examining interventions like implicit bias educational modules and arthroscopic partial meniscectomy. These cities provide individuals with osteoarthritis access to cutting-edge clinical trials that could lead to improved treatment options and enhanced quality of life.

Which are the top treatments for osteoarthritis being explored in clinical trials?

Osteoarthritis research is advancing, with several promising treatments currently being explored in clinical trials. Leading the way is a combination of StroMed and platelet rich plasma (PRP), which shows potential as an effective intervention for osteoarthritis. Another contender is RTX-GRT7039, a novel treatment option that holds promise for managing this degenerative joint disease. Additionally, emerging therapies such as cannabidiol (CBD) are also under investigation for their potential to alleviate osteoarthritis symptoms. Finally, adipose-derived (AD) stromal vascular fraction (SVF) therapy presents another avenue worth exploring in the pursuit of effective osteoarthritis treatments. As these clinical trials unfold, hope continues to grow for improved outcomes and better quality of life for individuals suffering from osteoarthritis.

What are the most recent clinical trials for osteoarthritis?

Recent clinical trials have brought new hope to those suffering from osteoarthritis. One groundbreaking study focused on the use of bone marrow aspirate concentrate, which has shown promising results in alleviating symptoms and improving joint function. Another trial investigated the effects of MPL-001, a CBD:THC compound, as a potential treatment for osteoarthritis. Additionally, ketorolac injections delivered directly to affected joints have been explored as an effective method for pain relief. The real IPACK block is another innovative approach being studied for its potential benefits in managing osteoarthritis symptoms. Furthermore, RTX-GRT7039 has emerged as a possible therapeutic option that warrants further investigation and could potentially provide significant relief to individuals living with this debilitating condition.

What osteoarthritis clinical trials were recently completed?

In recent years, multiple clinical trials have been conducted to advance our understanding and treatment options for osteoarthritis. Noteworthy among these studies are the following completed trials: a trial investigating the Sustained Acoustic Device with 2.5% Diclofenac Patch by ZetrOZ, Inc., completed in February 2022; a trial evaluating LY356318 sponsored by Eli Lilly and Company that concluded in October 2021; and another study examining semaglutide 2.4 mg sponsored by Novo Nordisk A/S, also completed in October 2021. These trials demonstrate ongoing efforts to address osteoarthritis through innovative approaches and offer hope for future treatments targeted at this prevalent condition impacting millions worldwide.